Multinational Drugmaker Activity To Remain Limited Despite Rising Diabetes Disease Burden In Cambodia
- A shift in lifestyle will remain responsible for rising diabetes burden in Cambodia.
- Commercial opportunities for drugmakers in Cambodia will remain limited despite the rising burden of both communicable and non-communicable diseases.
- Revenue prospects for high-value medicines remain limited due to the low purchasing power of the population and the dominance of out-of-pocket spending in healthcare financing.
A shift in lifestyle will remain responsible for rising diabetes burden in Cambodia. While the population will continue to suffer from a significant underlying burden of communicable diseases, the burden of